Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Brain & nervous system
Sign up for latest coverage
Submit your event
cancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Prevention & screening
Middle East and North Africa
Central America and the Caribbean
Australia and Oceania
9 - 12 Dec 2017
Georgia World Congress Center, Atlanta, United States of America
ASH 2017: Study identifies agent that can reverse resistance to targeted drug in some leukaemia
ASH 2017: People aged 75 years and older are underrepresented in blood cancer clinical trials
ASH 2017: Targeted leukaemia drug venetoclax found superior to standard chemotherapy for broad range...
ASH 2017: Largest-ever trial shows direct oral anticoagulants are a viable option for treating blood...
ASH 2017: Trial supports addition of daratumumab to standard treatment regimen for patients with mul...
ASH 2017: AML study reports high response rates with combination targeted therapy
ASH 2017: Responses to CAR T-cell therapy still strong after one year in patients with refractory NH...
ASH 2017: Six-month analysis of tisagenlecleucel in stubborn form of lymphoma shows sustained respon...
ASH 2017: Clinical activity seen with anti-BCMA CAR T-cell therapy in phase 1 study of people with h...
ASH 2017: Targeted antibody mogamulizumab superior to vorinostat for previously treated CTCL in phas...
ASH 2017: Addition of targeted drug reduces risk of first-line treatment failure in advanced Hodgkin...
ASH 2017: Combination treatment with two targeted agents shows promise in previously treated CLL
ASH 2017: Rapid responses, few adverse effects seen with targeted agent in Phase I trial in rare blo...
For leukaemia patients, transfusion needs may delay hospice care
ASH 2017: Sustained benefit with Ibrutinib in r/r MCL
ASH 2017: Direct oral anticoagulant reduces recurrence of harmful clots in patients with cancer